NASDAQ · Analyst Forecast

NovaBridge Biosciences (NBP) Analyst Forecast

$1.40 NASDAQ: NBP Market Cap $160.80M

Revenue and earnings estimates published by analysts covering NovaBridge Biosciences (NBP), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For NovaBridge Biosciences, the average estimate for 2030 earnings per share is $-2.68; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

Measure	Value
Current priceWhat the share trades at now.	$1.40
Consensus targetThe average of the price targets analysts have published.	$8.25
Median targetThe middle target, less affected by a single outlier.	$8.50
Highest targetThe most optimistic published target.	$9.00
Lowest targetThe most pessimistic published target.	$7.00
Difference from priceHow far the consensus target sits from today’s price.	+489.3%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2025	$0	$0	$0	1
2026	$0	$0	$0	1
2027	$0	$0	$0	1
2028	$97.89T	$97.89T	$97.89T	2
2029	$162.54T	$162.54T	$162.54T	1
2030	$248.69T	$248.69T	$248.69T	1

Earnings per share forecast

Year	Low	Average	High	Analysts
2025	$-0.88	$-0.77	$-0.63	1
2026	$-4.06	$-4.06	$-4.06	1
2027	$-4.36	$-4.36	$-4.36	1
2028	$-4.06	$-4.06	$-4.06	2
2029	$-3.65	$-3.65	$-3.65	1
2030	$-2.68	$-2.68	$-2.68	1

NovaBridge Biosciences (NBP) forecast — frequently asked questions

What is the analyst price target for NovaBridge Biosciences?

Analysts covering NovaBridge Biosciences (NBP) have a consensus price target of $8.25, 489.3% above the current price of $1.40. Published targets range from $7.00 to $9.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for NovaBridge Biosciences's earnings?

The average analyst estimate for NovaBridge Biosciences (NBP) earnings per share in 2030 is -2.68, with individual estimates between -2.68 and -2.68.

How much revenue is NovaBridge Biosciences expected to make?

Analysts forecast NovaBridge Biosciences (NBP) revenue of $248.69T in 2030, based on 1 published estimates.

How many analysts cover NBP?

2 analysts contribute estimates for NovaBridge Biosciences (NBP). Thin coverage makes an average less reliable.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.